Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 961438, 13 pages
http://dx.doi.org/10.1155/2014/961438
Research Article

The Effects of Omega-3 Fatty Acid Supplementation on Dexamethasone-Induced Muscle Atrophy

Department of Neurology, University of São Paulo, No. 455, Dr. Arnaldo Avenue, 01246-903 São Paulo, SP, Brazil

Received 18 March 2014; Accepted 28 April 2014; Published 25 May 2014

Academic Editor: Emanuele Marzetti

Copyright © 2014 Alan Fappi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Schiaffino, K. A. Dyar, S. Ciciliot, B. Blaauw, and M. Sandri, “Mechanisms regulating skeletal muscle growth and atrophy,” The FEBS Journal, vol. 280, no. 17, pp. 4294–4314, 2013. View at Google Scholar
  2. S. C. Kandarian and R. W. Jackman, “Intracellular signaling during skeletal muscle atrophy,” Muscle and Nerve, vol. 33, no. 2, pp. 155–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Voisin D Breuillé and L. Combaret C Pouyet D Taillandier E Aurousseau C Obled D Attaix, “Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+-activated, and ubiquitin-proteasome proteolytic pathways,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1610–1617, 1996. View at Google Scholar
  4. J. K. Clark, W. T. Schrader, and B. W. O'Malley, “Mechanism of steroid hormones,” in Willians Textbook of Endocrinology, D. Wilson and D. W. Foster, Eds., pp. 35–90, WB Sanders, Philadelphia, Pa, USA, 1992. View at Google Scholar
  5. U. C. Reed, “Neuromuscular disorders,” Journal of Pediatrics, vol. 78, supplement 1, pp. S89–S103, 2002. View at Google Scholar
  6. F. J. Kelly and D. F. Goldspink, “The differing responses of four muscle types to dexamethasone treatment in the rat,” Biochemical Journal, vol. 208, no. 1, pp. 147–151, 1982. View at Google Scholar · View at Scopus
  7. H. Gilson, O. Schakman, L. Combaret et al., “Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy,” Endocrinology, vol. 148, no. 1, pp. 452–460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Schakman, H. Gilson, S. Kalista, and J. P. Thissen, “Mechanisms of muscle atrophy induced by glucocorticoids,” Hormone Research, vol. 72, supplement 1, pp. 36–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Komamura, H. Shirotani-Ikejima, R. Tatsumi et al., “Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray,” Cardiovascular Drugs and Therapy, vol. 17, no. 4, pp. 303–310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Wang, N. Kubica, L. W. Ellisen, L. S. Jefferson, and S. R. Kimball, “Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1,” Journal of Biological Chemistry, vol. 281, no. 51, pp. 39128–39134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. P. Verhees, A. M. W. J. Schols, M. C. J. M. Kelders, C. M. H. O. den Kamp, J. L. J. van der Velden, and R. C. J. Langen, “Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy,” The American Journal of Physiology: Cell Physiology, vol. 301, no. 5, pp. C995–C1007, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ciciliot, A. C. Rossi, K. A. Dyar, B. Blaauw, and S. Schiaffino, “Muscle type and fiber type specificity in muscle wasting,” The International Journal of Biochemistry and Cell Biology, vol. 5, no. 10, pp. 2191–2199, 2013. View at Google Scholar
  13. M. Sandri, C. Sandri, A. Gilbert et al., “Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy,” Cell, vol. 117, no. 3, pp. 399–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Schakman, H. Gilson, and J. P. Thissen, “Mechanisms of glucocorticoid-induced myopathy,” Journal of Endocrinology, vol. 197, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. N. Stitt, D. Drujan, B. A. Clarke et al., “The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors,” Molecular Cell, vol. 14, no. 3, pp. 395–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Brunet, A. Bonni, M. J. Zigmond et al., “Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor,” Cell, vol. 96, no. 6, pp. 857–868, 1999. View at Google Scholar · View at Scopus
  17. Y. Wu, W. Zhao, J. Zhao et al., “REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss,” Endocrinology, vol. 151, no. 3, pp. 1050–1059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Delgado-Lista, P. Perez-Martinez, J. Lopez-Miranda, and F. Perez-Jimenez, “Long chain omega-3 fatty acids and cardiovascular disease: a systematic review,” British Journal of Nutrition, vol. 107, supplement 2, pp. 201–213, 2012. View at Google Scholar
  19. A. P. Simopoulos, “Omega-6/omega-3 essential fatty acids: biological effects,” World review of nutrition and dietetics, vol. 99, pp. 1–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. P. Simopoulos, “Omega-3 fatty acids in inflammation and autoimmune diseases,” Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495–505, 2002. View at Google Scholar · View at Scopus
  21. World Health Organization, “Interim Summary of Conclusions and Dietary Recommendations on Total Fat,” http://www.who.int/nutrition/topics/FFA_summary_rec_conclusion.pdf.
  22. FDA, “FDA Announces Qualified Health Claims for Omega-3 Fatty Acids,” 2004, http://www.fda.gov/newsevents/newsroom/pressannouncements/2004/ucm108351.htm.
  23. American Heart Association, “Fish 101,” 2014, http://www.heart.org/HEARTORG/GettingHealthy/NutritionCenter/Fish-101_UCM_305986_Article.jsp.
  24. M. E. Surette, “The science behind dietary omega-3 fatty acids,” Canadian Medical Association Journal, vol. 178, no. 2, pp. 177–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Whitehouse, H. J. Smith, J. L. Drake, and M. J. Tisdale, “Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid,” Cancer Research, vol. 61, no. 9, pp. 3604–3609, 2001. View at Google Scholar · View at Scopus
  26. E. G. Bligh and W. J. Dyer, “A rapid method of total lipid extraction and purification,” Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911–917, 1959. View at Google Scholar · View at Scopus
  27. S. J. Iverson, S. L. C. Lang, and M. H. Cooper, “Comparison of the bligh and dyer and folch methods for total lipid determination in a broad range of marine tissue,” Lipids, vol. 36, no. 11, pp. 1283–1287, 2001. View at Google Scholar · View at Scopus
  28. N. Shirai, H. Suzuki, and S. Wada, “Direct methylation from mouse plasma and from liver and brain homogenates,” Analytical Biochemistry, vol. 343, no. 1, pp. 48–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. W. Ogilvie and D. L. Feeback, “A metachromatic dye-ATPase method for the simultaneous identification of skeletal muscle fiber types I, IIA, IIB ands IIC,” Stain Technology, vol. 65, no. 5, pp. 231–241, 1990. View at Google Scholar · View at Scopus
  30. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  31. S. Dasarathy, M. Dodig, S. M. Muc, S. C. Kalhan, and A. J. McCullough, “Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 287, no. 6, pp. G1124–G1130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Chen, S. Chen, W. Wang, F. Liu, C. Zhang, and H. Zheng, “Modulation of satellite cells in rat facial muscle following denervation and delayed reinnervation,” Acta Oto-Laryngologica, vol. 130, no. 12, pp. 1411–1420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Murakami, K. Hasegawa, and M. Yoshinaga, “Rapid induction of REDD1 expression by endurance exercise in rat skeletal muscle,” Biochemical and Biophysical Research Communications, vol. 405, no. 4, pp. 615–619, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Pires-Oliveira, A. L. G. C. Maragno, L. T. Parreiras-e-Silva, T. Chiavegatti, M. D. Gomes, and R. O. Godinho, “Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo,” Journal of Applied Physiology, vol. 108, no. 2, pp. 266–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Janjoppi, M. H. Katayama, F. A. Scorza et al., “Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine,” Brain Research Bulletin, vol. 76, no. 5, pp. 480–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. H. J. Smith, P. Mukerji, and M. J. Tisdale, “Attenuation of proteasome-induced proteolysis in skeletal muscle by β-hydroxy-β-methylbutyrate in cancer-induced muscle loss,” Cancer Research, vol. 65, no. 1, pp. 277–283, 2005. View at Google Scholar · View at Scopus
  37. J. Khal and M. J. Tisdale, “Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA),” Biochemical and Biophysical Research Communications, vol. 375, no. 2, pp. 238–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. S. Whitehouse and M. J. Tisdale, “Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation,” Biochemical and Biophysical Research Communications, vol. 285, no. 3, pp. 598–602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. F. J. Soriguer, F. J. Tinahones, A. Monzón et al., “Varying incorporation of fatty acids into phospholipids from muscle, adipose and pancreatic exocrine tissues and thymocytes in adult rats fed with diets rich in different fatty acids,” European Journal of Epidemiology, vol. 16, no. 6, pp. 585–594, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Le Foll, C. Corporeau, V. Le Guen, J.-P. Gouygou, J.-P. Bergé, and J. Delarue, “Long-chain n-3 polyunsaturated fatty acids dissociate phosphorylation of Akt from phosphatidylinositol 3′-kinase activity in rats,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 292, no. 4, pp. E1223–E1230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. K. Abbott, P. L. Else, and A. J. Hulbert, “Membrane fatty acid composition of rat skeletal muscle is most responsive to the balance of dietary n-3 and n-6 PUFA,” British Journal of Nutrition, vol. 103, no. 4, pp. 522–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. M. Bando, M. Fournier, X. Da, and M. I. Lewis, “Effects of malnutrition with or without eicosapentaenoic acid on proteolytic pathways in diaphragm,” Respiratory Physiology and Neurobiology, vol. 180, no. 1, pp. 14–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. Prezant, M. L. Karwa, B. Richner, D. Maggiore, E. I. Gentry, and J. Cahill, “Gender-specific effects of dexamethasone treatment on rat diaphragm structure and function,” Journal of Applied Physiology, vol. 82, no. 1, pp. 125–133, 1997. View at Google Scholar
  44. M. Sandri, J. Lin, C. Handschin et al., “PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 44, pp. 16260–16265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. R. M. Palmer and K. W. J. Wahle, “Protein synthesis and degradation in isolated muscle. Effect of ω3 and ω6 fatty acids,” Biochemical Journal, vol. 242, no. 2, pp. 615–618, 1987. View at Google Scholar · View at Scopus
  46. P. S. Sohal, V. E. Baracos, and M. T. Clandinin, “Dietary ω3 fatty acid alters prostaglandin synthesis, glucose transport and protein turnover in skeletal muscle of healthy and diabetic rats,” Biochemical Journal, vol. 286, no. 2, pp. 405–411, 1992. View at Google Scholar · View at Scopus
  47. M. L. Garg, E. Sebokova, A. B. R. Thomson, and M. T. Clandinin, “Δ6-Desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or ω3 fatty acids,” Biochemical Journal, vol. 249, no. 2, pp. 351–356, 1988. View at Google Scholar · View at Scopus
  48. M. J. Jackson, J. Roberts, and R. H. T. Edwards, “Effects of dietary-fish-oil feeding on muscle growth and damage in the rat,” British Journal of Nutrition, vol. 60, no. 2, pp. 217–224, 1988. View at Google Scholar · View at Scopus
  49. B. A. Clarke, D. Drujan, M. S. Willis et al., “The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle,” Cell Metabolism, vol. 6, no. 5, pp. 376–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Jones, D.-J. Hwang, R. Narayanan, D. D. Miller, and J. T. Dalton, “Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy,” Endocrinology, vol. 151, no. 8, pp. 3706–3719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A. P. Simopoulos, “Omega-3 fatty acids in health and disease and in growth and development,” The American Journal of Clinical Nutrition, vol. 54, no. 3, pp. 438–463, 1991. View at Google Scholar · View at Scopus
  52. D. J. Glass, “Molecular mechanisms modulating muscle mass,” Trends in Molecular Medicine, vol. 9, no. 8, pp. 344–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. Frost, D. Huber, A. Pruznak, and C. H. Lang, “Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes,” Journal of Cellular Biochemistry, vol. 108, no. 5, pp. 1192–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. R. M. R. Pereira and J. Freire de Carvalho, “Glucocorticoid-induced myopathy,” Joint Bone Spine, vol. 78, no. 1, pp. 41–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. F. W. te Pas, P. R. de Jong, and F. J. Verburg, “Glucocorticoid inhibition of C2C12 proliferation rate and differentiation capacity in relation to mRNA levels of the MRF gene family,” Molecular Biology Reports, vol. 27, no. 2, pp. 87–98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. O. Prelovsek, T. Mars, M. Jevsek, M. Podbregar, and Z. Grubic, “High dexamethasone concentration prevents stimulatory effects of TNF-α and LPS on IL-6 secretion from the precursors of human muscle regeneration,” The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 291, no. 6, pp. R1651–R1656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Castillero, A. I. Martín, M. López-Menduiña, M. A. Villanúa, and A. López-Calderón, “Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors,” The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 297, no. 5, pp. R1322–R1331, 2009. View at Publisher · View at Google Scholar · View at Scopus